Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : WDC/Sandisk Corporation -- Ignore unavailable to you. Want to Upgrade?

To: clix who wrote (27790)	3/29/2005 7:03:52 PM
From: Art Bechhoefer	Respond to of 60323

clix--Thanks for the analysis on exclusive and nonexclusive licenses. As you point out, it may depend on the specifics more than anything else. One company I follow granted an exclusive license to a firm, which, instead of producing the product, just sat on the license, as if to prevent the firm with the IP from gaining any profit. Exclusive licenses may be worse for the holder of the IP for that very reason. Unless there is no real market for the product, I think it would be in the best interest of the licensing company to grant as many licenses as possible. One pattern, however, which can be seen in the licensing of new drugs, is to grant an exclusive license for a particular trade area (e.g., Europe). While law school may lead to money making careers, I hope my grandchildren will pursue something more creative. Art